Assessing the public health benefits of reduced ozone concentrations

Environmental Health Perspectives

Volumn 109, Issue 12, 2001, Pages 1215-1226

  Levy, Jonathan I ^a   Carrothers, Timothy J ^b   Tuomisto, Jouni T ^c   Hammitt, James K ^d   Evans, John S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD CENTER FOR RISK ANALYSIS   (United States)

^c PHARSIGHT CORPORATION   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Benefit cost analysis; Epidemiology; Exposure assessment; Monetary valuation; Ozone; Premature mortality

Indexed keywords

OZONE;

AIR CONDITIONING; ASTHMA; CONCENTRATION (PARAMETERS); COST BENEFIT ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL PROTECTION; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HEALTH HAZARD; HOSPITAL ADMISSION; HUMAN; INFANT MORTALITY; OUTCOMES RESEARCH; POPULATION RESEARCH; PREMATURITY; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH; RESPIRATORY TRACT DISEASE; REVIEW; UNITED STATES;

EID: 0035680551     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.011091215     Document Type: Review

References (114)

1. Acute respiratory effects of particulate air pollution
2. A critical review of the evidence of particulate air pollution and mortality
3. Health effects of particulate air pollution: Time for reassessment?
4. Review of epidemiologic evidence of health effects of particulate air pollution
5. Air pollution and daily mortality
6. 10-mortality time-series studies
7. Estimating the mortality impacts of particulate matter: What can be learned from between-study variability?
8. Epidemiologic studies of acute ozone exposures and mortality
9. The environmental and disease: Association or causation?
10. Ozone and the lung: A sensitive issue
11. Acute and chronic effects of ozone in animal models
12. Antioxidant status in asthma
13. The effects of ambient ozone on lung function in children: A reanalysis of six summer camp studies
14. Effects of ozone and other pollutants on the pulmonary function of adult hikers
15. Effects of ambient ozone on respiratory function in healthy adults exercising outdoors
16. Mechanism of action of ozone on the human lung
17. Nociceptive mechanisms modulate ozone-induce human lung function decrements
18. Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects
19. Indomethacin does not inhibit the ozone-induced increase in bronchial responsiveness in human subjects
20. Pulmonary function and symptom responses after 6.6-hour exposure to 0.12 ppm ozone with moderate exercise
21. Ozone concentration and pulmonary response relationship for 6.6-hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm
22. Response to macaque bronchiolar epithelium to ambient concentrations of ozone
23. The respiratory system of nonhuman primates responds more to ambient concentration of ozone than does that of rats
24. Differential bronchial epithelium in alveolar ducts of rats exposed to ozone for 20 months
25. Epithelial injury and intestial fibrosis in the proximal alveolar regions of rats chronically exposed to a simulated pattern of urban ambient ozone
26. Effects of 20 months of ozone exposure on lung collagen in Fisher 344 rats
27. Effects of ozone on the postnatal development of lamb mucociliary apparatus
28. Comparison of daily and seasonal exposures of young monkeys to ozone
29. Centriacinar (CAR) Disease in the lungs of young adults: A preliminary report
30. Ozone in residential air: Concentrations, I/O ratios, indoor chemistry, and exposures
31. Modeling ozone levels in and around Southern California homes
32. Ozone exposure assessment in a Southern California community
33. Health effects of air pollution from traffic: Ozone and particulate matter
34. An association between air pollution and mortality in six US cities
35. Particulate air pollution as a predictor of mortality in a prospective study oef US adults
36. Long-term inhalable particles and other air pollutants related to mortality in non smokers
37. Pulmonary function in a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study
38. Effects of pulmonary function on mortality
39. Spirometric findings and mortality in never-smokers
40. Impaired lung function and mortality risk in men and women: Findings from the Renfrew and Paisley prospective population study
41. Decline in lung function and mortality: The Busselton Health Study
42. Modeling of air pollution impacts: One possible explanation of the observed cohort mortality
43. Long-term ambient ozone concentration and the incidence of asthma in nonsmoking adults: The AHSMOG study
44. A study of twelve Southern California communities with differing levels and types of air pollution. I. Prevalence of respiratory morbidity
45. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study)
46. The effects of monthly temperature fluctuations on mortality in the United States from 1921-1985
47. A synoptic evaluation of asthma hospital admissions in New York City
48. Weather and human mortality: An evaluation of demographic and interregional responses in the United States
49. Avaluation of climate/mortality relationships in large U.S. cities and the possible impact of a climate change
50. Air pollution and mortality in Philadelphia, 1974-1988
51. Synoptic weather modeling and estimates of the exposure-response relationship between daily mortality and particulate air pollution
52. Air pollution and daily mortality in Philadelphia
53. 10/mortality associations: An investigation of at-risk subpopulations
54. Air pollution and daily mortality in three U.S. counties
55. Effects of ambient particulate matter and ozone on daily mortality in Rotterdam, the Netherlands
56. Short-term effects of ambient oxidant exposure on mortality: A combined analysis within the APHEA project
57. 10 associations in Los Angeles
58. Meta-analysis in clinical trials
59. Modeling mortality fluctuations in Los Angeles as functions of pollution and weather effects
60. Particulate air pollution and daily mortality in Detroit
61. Air pollution and daily mortality: Associations with particulates and acid aerosols
62. Daily mortality and air pollution in Santa Clara County, California: 1989-1996
63. A time-series analysis of acidic particulate matter and daily mortality and morbidity in the Buffalo, New York, region
64. Associations between air pollution and mortality in Phoenix, 1995-1997
65. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan
66. Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities
67. Air pollution and hospital admissions for cardiovascular disease in Tucson
68. Air pollution and hospital admissions for heart disease in eight U.S. counties
69. Epidemiologic studies of ozone exposure effects
70. Effects of particulate and gaseous air pollution on cardiorespiratory hospitalizations
71. Detailed diagnoses and procedures: National Hospital Discharge Survey, 1997
72. Current estimates from the National Health Interview Survey, 1993
73. Air pollution and acute respiratory morbidity: An observational study of multiple pollutants
74. Ambient ozone and acute health effects: Evidence from daily data
75. Valuing mortality risk: Theory and practice
76. Public choices between lifesaving programs. How important are lives saved?
77. Environmental regulation, cost-benefit analysis, and the discounting of human lives
78. Are there sensitive subgroups for the effects of airborne particles?
79. The economics of risks to life
80. Survival versus competition
81. The value of changes in life expectancy
82. The older the more valuable: Divergence between utility and dollar values of life as one ages
83. Deaths: Final data for 1997
84. Harvesting and long term exposure effects in the relation between air pollution and mortality
85. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of COPD
86. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma
87. Measurement of consumer-patient preferences using a hybrid contingent valuation method
88. Trends in the cost of illness for asthma in the United States, 1985-1994
89. Oxidants and asthmatics in Los Angeles: A benefits analysis
90. Perspective: EPA's ozone standard may harm public health and welfare
91. UV-B screening by tropospheric ozone: Implications for the National Ambient Air Quality Standard